A major barrier to improving care effectiveness for mental health is a lack of consensus on
outcomes measurement. The International Consortium for Health Outcomes Measurement (…

Background Healthcare organizations, compendia, and drug knowledgebase vendors use
varying methods to evaluate and synthesize evidence on drug–drug interactions (DDIs). This …

BACKGROUND: Chronic wounds continue to be a major clinical problem and novel therapeutic
approaches are needed. We have previously demonstrated that treatment of diabetic …

Background Human breast cancer resistance protein (BCRP) is an ATP-binding cassette (ABC)
efflux transporter that confers multidrug resistance in cancers and also plays an …

This is the first large-scale study to define the injured population and examine associated
injuries for patients with tibial shaft fractures. Patients over 18 years of age in the National …

Many genetic variants associated with human disease have been found to be associated with
alterations in mRNA expression. Although it is commonly assumed that mRNA expression …

BACKGROUND: The COVID-19 pandemic resulted in disruption of healthcare services,
including cancer screenings, yet data on this are limited. We sought to compare observed and …

Study Design. A retrospective cohort study. Objective. The aim of this study was to determine
the incidence and risk factors for short-term morbidity following posterior spinal fusion (PSF) …

Background Efforts to minimize harms from opioid drug interactions may be hampered by
limited evidence on which drugs, when taken concomitantly with opioids, result in adverse …

Drugs that are mainly cleared by a single enzyme are considered more sensitive to drug–drug
interactions (DDIs) than drugs cleared by multiple pathways. However, whether this is true …